206 related articles for article (PubMed ID: 20637435)
21. Giant cell fibroblastoma: a report of three cases with histologic and immunohistochemical evidence of a relationship to dermatofibrosarcoma protuberans.
Goldblum JR
Arch Pathol Lab Med; 1996 Nov; 120(11):1052-5. PubMed ID: 12049108
[TBL] [Abstract][Full Text] [Related]
22. The molecular characterisation of unusual subcutaneous spindle cell lesion of breast.
Takano EA; Rogers TM; Young RJ; Rayoo M; Kostos P; Ferguson R; Campbell IG; Debiec-Rychter M; Fox SB
J Clin Pathol; 2012 Aug; 65(8):746-50. PubMed ID: 22523339
[TBL] [Abstract][Full Text] [Related]
23. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
[TBL] [Abstract][Full Text] [Related]
24. Giant cell fibroblastoma associated with dermatofibrosarcoma protuberans: a case report.
Maeda T; Hirose T; Furuya K; Shirakawa K; Kobayashi K
Mod Pathol; 1998 May; 11(5):491-5. PubMed ID: 9619604
[TBL] [Abstract][Full Text] [Related]
25. Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report.
Chen Y; Shi YZ; Feng XH; Wang XT; He XL; Zhao M
Diagn Pathol; 2021 Jul; 16(1):63. PubMed ID: 34256767
[TBL] [Abstract][Full Text] [Related]
26. Myxoid variant of dermatofibrosarcoma protuberans with fibrosarcomatous areas.
Zámecnik M; Michal M
Zentralbl Pathol; 1993 Nov; 139(4-5):373-6. PubMed ID: 8130169
[TBL] [Abstract][Full Text] [Related]
27. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.
Llombart B; Serra-Guillén C; Monteagudo C; López Guerrero JA; Sanmartín O
Semin Diagn Pathol; 2013 Feb; 30(1):13-28. PubMed ID: 23327727
[TBL] [Abstract][Full Text] [Related]
28. Hyalinized collagen in a dermatofibrosarcoma protuberans after treatment with imatinib mesylate.
Thomison J; McCarter M; McClain D; Golitz LE; Goldenberg G
J Cutan Pathol; 2008 Nov; 35(11):1003-6. PubMed ID: 18544062
[TBL] [Abstract][Full Text] [Related]
29. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
Macarenco RS; Zamolyi R; Franco MF; Nascimento AG; Abott JJ; Wang X; Erickson-Johnson MR; Oliveira AM
Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
[TBL] [Abstract][Full Text] [Related]
30. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
Fanburg-Smith JC; Miettinen M
Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
[TBL] [Abstract][Full Text] [Related]
31. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
Kovarik CL; Hsu MY; Cockerell CJ
J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
[TBL] [Abstract][Full Text] [Related]
32. Fibrosarcomatous transformation in dermatofibrosarcoma protuberans of the breast--a case report.
Kim MS; Kim KS; Han HY; Kang YJ; Choi YJ; Kang DW; Kim JH
J Clin Ultrasound; 2009 Sep; 37(7):420-3. PubMed ID: 19536861
[TBL] [Abstract][Full Text] [Related]
33. PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.
Jahanseir K; Xing D; Greipp PT; Sukov WR; Keeney GL; Howitt BE; Schoolmeester JK
Int J Gynecol Pathol; 2018 Nov; 37(6):537-546. PubMed ID: 29140881
[TBL] [Abstract][Full Text] [Related]
34. Myoid differentiation and EMA expression in fibrosarcomatous dermatofibrosarcoma protuberans.
Arican O; Bakaris S; Bulbuloglu E; Ezberci F
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Mar; 15(1):39-44. PubMed ID: 16850098
[TBL] [Abstract][Full Text] [Related]
35. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.
Kesserwan C; Sokolic R; Cowen EW; Garabedian E; Heselmeyer-Haddad K; Lee CC; Pittaluga S; Ortiz C; Baird K; Lopez-Terrada D; Bridge J; Wayne AS; Candotti F
J Allergy Clin Immunol; 2012 Mar; 129(3):762-769.e1. PubMed ID: 22153773
[TBL] [Abstract][Full Text] [Related]
36. [Myxoid dermatofibrosarcoma protuberans in childhood].
Campos M; Zarco C; Acquadro F; Riveiro-Falkenbach E; Rodríguez-Peralto JL
Actas Dermosifiliogr; 2012 Jun; 103(5):422-6. PubMed ID: 21872834
[TBL] [Abstract][Full Text] [Related]
37. [Dermatofibrosarcoma protuberans of the breast: a case report].
Valli R; Rossi G; Natalini G; Losi L
Pathologica; 2002 Dec; 94(6):310-3. PubMed ID: 12540995
[TBL] [Abstract][Full Text] [Related]
38. A progression to dermatofibrosarcoma protuberans with a fibrosarcomatous component: a special reference to the chromosomal aberrations.
Hamada M; Hirakawa N; Fukuda T; Furue M; Hori Y; Tsuneyoshi M
Pathol Res Pract; 1999; 195(7):451-60. PubMed ID: 10448661
[TBL] [Abstract][Full Text] [Related]
39. Cytologic diagnostic pitfall of dermatofibrosarcoma protuberans masquerading as primary parotid tumor: a case report.
Siddaraju N; Singh N; Murugan P; Wilfred CD; Chahwala Q; Soundararaghavan J
Diagn Cytopathol; 2009 Apr; 37(4):277-80. PubMed ID: 19217036
[TBL] [Abstract][Full Text] [Related]
40. Dermatofibrosarcoma protuberans of the vulva: clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature.
Ghorbani RP; Malpica A; Ayala AG
Int J Gynecol Pathol; 1999 Oct; 18(4):366-73. PubMed ID: 10542946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
